
DR Congo Ebola Cases Exceed 4,000 Amid Worsening Crisis
The Ebola outbreak in the Democratic Republic of Congo has surpassed 4,000 confirmed cases, with over 1,850 deaths reported. The World Health Organization is urging trials for the Ervebo vaccine and considering wider use of Gilead's Remdesivir to combat the rapidly spreading disease.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Excellent (92/100)Sources
Congo Ebola Outbreak: Merck Ervebo Vaccine, Gilead Remdesivir Eyed for Wider Use
Merck & Co.’s Ebola vaccine and an antiviral drug from Gilead Sciences Inc. are set for wider use in eastern Democratic Republic of Congo to blunt the fastest-growing Ebola outbreak on record.
By Janice Kew and Jason Gale
Read full article →Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial
The Bundibugyo epidemic, the world's second-largest, has been described as the fastest-spreading on record.
Read full article →Ebola outbreak in Congo tops 4,000 cases in world's second-largest epidemic
Researchers believe Congo's Ebola outbreak began months before it was officially declared, with the true scale of infections likely much higher.
Read full article →Congo battles worsening Ebola crisis as cases top grim 4,000 mark
The Democratic Republic of Congo's Ebola outbreak has surpassed 4,000 confirmed cases for the first time, underscoring the scale of the country's worst-ever epidemic and...
Read full article →


